Carmell Therapeutics Corporation (CTCX) — Defensive Interval Ratio

Latest as of March 2025: 5 days

Carmell Therapeutics Corporation (CTCX) has a Defensive Interval Ratio of 5 days as of March 2025. Defensive assets of $94.75K (cash $-, short-term investments $-, receivables $94.75K) cover 5 days of daily cash needs of $18.08K/day.

Defensive Interval Ratio

5 days
Days of operational coverage

Defensive Assets

$94.75K
Cash + ST Investments + Receivables

Daily Cash Need

$18.08K
Current Liabilities ÷ 365

Current Liabilities

$6.60 Million
USD

Carmell Therapeutics Corporation Defensive Interval Ratio (2023–2024)

This chart shows how Carmell Therapeutics Corporation's Defensive Interval Ratio has evolved across 2 annual periods from 2023 to 2024. As of March 2025, the ratio stands at 5 days, meaning defensive assets of $94.75K can fund 5 days of operations without new revenue. For the complete balance sheet picture, see Carmell Therapeutics Corporation asset portfolio.

Annual Defensive Interval Ratio for Carmell Therapeutics Corporation (2023–2024)

The table below presents the year-by-year Defensive Interval Ratio for Carmell Therapeutics Corporation from 2023 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See CTCX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 19 days $305.93K $16.10K/day $- $- ▲ +17 days
2023 2 days $204.56K $105.49K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)